ReviewJournal of thoracic disease2018
Arterial events in cancer patients-the case of acute coronary thrombosis.
Review in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 39 citations in OpenAlex.
- Chemotherapy-associated coronary thrombosis presenting as acute coronary syndrome in breast cancer: a case report.BMC cardiovascular disorders · 2026Article
- Coronary artery calcification burden in cancer vs. non-cancer populations: a systematic review and meta-analysis.Cardio-oncology (London, England) · 2026Article
- Cancer history and mortality risk in acute myocardial infarction: Insights from the Japan AMI registry.International journal of cardiology. Heart & vasculature · 2025Article
- Prognostic Significance and Functional Mechanism of UTS2 in Glioblastoma Multiforme.Current cancer drug targets · 2025Article
- Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer.JACC. CardioOncology · 2023Article
- Lung cancer presenting with acute myocardial infarction and pulmonary embolism within 1 month.SAGE open medical case reports · 2023Article
- Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes.Reviews in cardiovascular medicine · 2022Review
- The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.Journal of clinical medicine · 2022Review
- Interventional Strategies in Cancer-induced Cardiovascular Disease.Current oncology reports · 2021Review
- Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History.Journal of the American Heart Association · 2021Observational
- Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention.JACC. Cardiovascular interventions · 2021Article
- Article
- Article
- Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity.Frontiers in pharmacology · 2021Review
- Characteristics, Management, and Outcomes of Acute Coronary Syndrome Patients with Cancer.Journal of clinical medicine · 2020Review
- Leukemoid reaction causing arterial thrombus in a patient with lung adenocarcinoma.BMJ case reports · 2020Article
- Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer: Looking for Something Heavier Than Heavy Metal.JACC. CardioOncology · 2020Article
- Vascular toxic effects of cancer therapies.Nature reviews. Cardiology · 2020Review
- Optimal management of coronary artery disease in cancer patients.Chronic diseases and translational medicine · 2019Review
- Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding?Journal of cancer research and clinical oncology · 2019Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Patients with cancer are at high risk for both venous and arterial thrombotic complications. A variety of factors account for the greater thrombotic risk, including the underlying malignancy and numerous cancer-directed therapies. The occurrence of an acute thrombotic event in patients with cancer is associated with substantial morbidity and mortality. Acute coronary syndrome (ACS) represents a particularly important cardiovascular complication in cancer patients. With cardio-vascular risk factors becoming more prevalent in an aging cancer population that is surviving longer, questions pertaining to the appropriate management of vascular toxicity are likely to assume even greater value in the coming years. In this article, we review the current understanding of ACS in patients with cancer. The predisposition to thrombosis in a malignant host and the cancer treatments most commonly associated with vascular toxicity are reviewed. Risk prediction and management strategies are discussed, and discrepancies in the clinical evidence are highlighted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.